Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo (vol 4, pg 926, 2021)

Authors:

Abstract
No abstract available
Funding Information
  • The Scientific and Technological Research Council of Turkey (TUBITAK) and NIH-NCI (1R01CA244344 grants, 215S008 and)